Ischemic Cholangiopathy After Controlled Donation After Cardiac Death Liver Transplantation
Colleen L. Jay(Northwestern University), Anton Skaro(Comprehensive Clinical Research), Vadim Lyuksemburg(Comprehensive Clinical Research), Jane L. Holl(University of Chicago), Michaël Abécassis(University of Arizona), Daniela P. Ladner(Northwestern University), Edward Wang, Juan Carlos Caicedo(Broad Institute)
Cited by 309
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
CellProfiler 3.0: Next-generation image processing for biology
|PLoS Biology|2018|2.1k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
|Liver Transplantation|2010|1.2k